Resistance to β-lactams in Enterobacteriaceae has been increasing worldwide. This study aimed to determine the frequency of β-lactamase genes and antibiotic resistance rates of 140 extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates obtained from urinary tract infection in Ordu Province, Turkey. Isolates were identified by classic methods and by automated system. ESBL production was confirmed by double disk synergy test and antimicrobial susceptibility was investigated by disk diffusion method. All isolates were screened for β-lactamase coding genes from three groups (A, B, and D) by polymerase chain reaction. The highest rate of susceptible isolates was observed for imipenem (IPM, 99.3%) and ertapenem (ETP, 97.9%), and the highest rate of resistant isolates was observed for cefuroxime (97.9%), ceftriaxone (97.2%), and cefazolin (90.7%). In our study, bla CTX-M1-like group was the most prevalent β-lactamase (n = 109), followed by bla TEM (n = 68), bla CTX-M2 (n = 22), and bla SHV (n = 2). By contrast to low resistance rate to IPM and ETP, we determined bla NDM in 31 isolates (22.1%). In co-prevalence of bla NDM-1 and ESBL-coding genes, a low carbapenem resistance was determined. We can confirm that bla CTX-M1-types are still the most frequent β-lactamase coding gene in Turkey. Our study showed the highest prevalence of bla NDM-1 metallo-β-lactamase coding gene in ESBL-producing E. coli.
Introduction
Korea, Malaysia, and Taiwan revealing ESBL-producing strains ranges from 30% to 40% [8] . In a meta-analysis from Turkey, a lower than 20% ESBL rate was found [9] . In another study from Hungary, the predominant gene of CTX-M-15 in ESBL-producing isolates was reported [10] . Molecular characterization of ESBLs was examined in E. coli isolates from 10 centers between the years 2011 and 2012. The resistance against carbapenems in bacteria is mostly related to carbapenemases such as oxacillinases carbapenem-hydrolyzing class D β-lactamases encoded by bla OXA genes, metallo-β-lactamases (MBLs) of IMP, VIM, and NDM types, and carbapenemases of Ambler class A as KPC and GES [11] . The aim of this study was to determine the prevalence of ESBL-producing E. coli, their drug resistance pattern to commonly used antibiotics in medical practice, and β-lactamase coding genes in these multidrug resistant isolates of urine samples taken from patients diagnosed with UTIs.
Materials and Methods

Bacterial strains and antimicrobial susceptibility test
One hundred and forty ESBL-positive E. coli isolates were isolated from urine cultures in the Medical Microbiology Laboratory of Ordu Training and Research Hospital between August 2014 and April 2015 and they were described according to Clinical and Laboratory Standards Institute (CLSI) criteria [12] . Identification of isolates taken from adult and pediatric patients attending a variety of clinics was completed by using classic methods and by Vitek-2Compact (bioMérieux, France) automated system. Isolates were stored in glcyerol LuriaBertani Broth medium at −80°C until the day of study. Antimicrobial susceptibility tests were performed by disk diffusion method (Oxoid, UK) using ampicillin (AM), sulbactam/ampicillin, amoxicillin-clavulanic acid (AMC), ceftazidime (CAZ), ceftriaxone (CTX), cefuroxime (CXM), cefazolin (CZ), cefepime (FEP), gentamicin (GN), tobramycin, levofloxacin (LEV), ciprofloxacin (CIP), nitrofurantoin (F), tetracycline (TE), ertapenem (ETP), imipenem (IPM), and SXT antibiotic disks and the results were evaluated according to the CLSI guidelines [12] .
The detection of ESBLs
Phenotypic ESBL production was confirmed by double disk synergy test. MHA media were seeded with a swab with E. coli strains on 0.5 McFarland prepared suspension and left at room temperature for 15 min. An AMC (20/10 μg) disk was placed in the center with CAZ (30 μg/disk), CTX (CRO; 30 μg/disk), β-LACTAMASE GENES IN ESBL-POSITIVE E. COLIcefotaxime (CTX; 30 μg/disk), and ATM (30 μg/disk) disks placed around the edges 25-30 mm from the center. Results were assessed after 18-24 h incubation at 35°C. This phenotypic ESBL screening test is based on the demonstration of a synergy image between AMC and cefotaxime, CAZ, and ATM, according to the guidelines of the CLSI. E. coli ATCC 25922 was used for control strain.
Multiplex PCR for detection of bla OXA and bla CTX-M genes Genomic DNAs were purified from overnight bacterial culture grown in 3 mL of Luria-Bertani broth using the Wizard Genomic DNA Purification Kit (Promega, Madison, WI, USA) following the manufacturer's instructions. Multiplex PCR was used to detect bla OXA-23-24-51 and 58-like and bla CTX-M-1/M-2 genes using primers listed in Table I . PCRs were performed in a final volume of 50 μL and included 5 μL of genomic DNA, 20 pM of each primer, 10 μL of 10X polymerase activity buffer, 3 μL of 25 mM MgCl 2 , 200 μM of each deoxynucleotide triphosphates (dNTPs), and 1.5 U of Taq Polymerase (Fermentas Thermo Fisher Scientific Inc., Waltham, USA). PCR amplification was performed using initial denaturation at 94°C for 3 min followed by 30 cycles of 25 s at 94°C, 40 s at 52°C, and 50 s at 72°C for bla OXA genes and initial denaturation at 95°C for 2 min followed by 30 cycles of 1 min at 95°C, 1 min at 55°C, and 1 min at 72°C for bla CTX-M-1/M-2 genes with a final extension of 5 min at 72°C. All PCR results were analyzed on 1% agarose containing 0.5 mg/L ethidium bromide, subsequently visualized under UV light and evaluated according to their molecular size.
PCR amplifications of ESBL and MBL resistance genes
The primers and PCR amplification conditions used to detect ESBLs and MBLs genes are shown in Table I . The reactions were performed in 50 μL final reaction volume using 5 μL of genomic DNA, 20 pM of each primer, 5 μL of reaction buffer, 3 μL of 25 mM MgCl 2 , 200 μL of dNTPs, and 1 U Go Taq Polymerase (Fermentas Thermo Fisher Scientific Inc., Waltham, USA). The results were run as above and evaluated according to their molecular size and PCR results of control groups, which were defined as β-lactamase gene carrier bacteria in the earlier studies [18] [19] [20] . Positive PCR products except bla OXA-23-24-51-58 , bla CTX-M1/M2 , bla TEM , and bla SHV were sent to Macrogen Inc., Seoul, Korea, to sequence by using the same primers used in PCR reactions. Sequencing results were analyzed using the alignment search tool BLAST (http:// www.ncbi.nlm.nih.gov/BLAST) and the multiple sequence alignment program CLUSTALW (http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
Results
Isolates were obtained from 140 urine samples from 64 pediatric and 76 adult patients. The study group was comprised of 94 females and 46 males with the mean pediatric age of 11.4 ± 3.8 years and the mean adult age of 38.6 ± 14.8 years. Of these isolates, 18 were from hospitalized patients with 122 from clinic outpatients, 7 (5%) intensive care, 43 (30.7%) pediatric, 23 (16.4%) urology, 18 (12.9%) emergency service, 13 (9.3%) infectious diseases, and 36 (25.7%) from other departments. 140 ESBL-positive urine isolates were susceptible to the following antibiotics: IPM with 99.3% and ETP with 99.7%, while the most resistant isolates were against CXM (97.9%), CTX (97.2%), and CZ (90.7%), respectively. All strains were found to be AM resistant. The susceptibility rates of E.coli strains showing multiple drug resistance for all antibiotics tested are shown in Table II. According to PCR results, bla CTX-M1 was the most prevalent β-lactamase 77.8% (109/140), followed by bla TEM 48.6% (68/140), bla CTX-M2 15.7% (22/140), and bla SHV 1.42% (2/140). More specifically, we determined bla NDM in 31 isolates (22.1%) and they were all confirmed as bla NDM-1 variant according to the sequencing result. No other β-lactamases were identified among the samples. 
Discussion
Characteristics of antimicrobial resistance show differences among regions, hospitals, and even departments. Although wild-type E. coli strains are susceptible to commonly used antimicrobial agents in the treatment of UTIs, antibiotic resistance in uropathogenic E. coli infections is increasing worldwide. Some factors such as common use and misuse of antibiotics both in hospitals by health professionals and in the community by self-prescription, and inadequate antimicrobial surveillance programs are the reasons for increasing bacterial resistance rates [21] . The susceptibility of ESBL-producing E. coli isolates to broad spectrum cefalosporins shows variety. In an earlier study from Turkey, all strains were identified to be susceptible to IPM, meropenem, and amikacin and all isolates were observed to be resistant to cefotaxime and CTX. Susceptibility rates to cefoxitin, ETP, cefoperazone/sulbactam, piperacillin/tazobactam, GN, CIP, FEP, AMC, ATM, and CAZ were 96%, 83%, 63%, 61%, 50%, 41%, 25%, 21%, 20%, and 18%, respectively [22] . In recent years, carbapenem resistance has been encountered in ESBL-producing E. coli from Turkey and some studies found 100% susceptibility for meropenem and IPM and varying rates of ETP susceptibility (from 99.2% to 83%) for ESBL-producing E. coli strains [23, 24] . In our study, similar to other studies, the isolates were mostly susceptible to IPM at 99.3% and ETP at 99.7%, while they were mostly resistant against cefuroxime-axetil (99.3%), CXM (97.9%), CTX (97.2%), and CZ (90.7%).
TEM and SHV types of ESBL-producing organisms are primarily nosocomial and they are produced by many enteric bacteria. Especially CTX-M type has been increasingly reported worldwide. CTX-M-type ESBL-producing E. coli pathogens have become an important cause of community-onset blood stream infections and UTIs [25] . The epidemiological characteristics of infections caused by CTX-M-type ESBLs are different from the TEM or SHV type and they are often isolated from the patients with community-onset infections. A study in America in 2000 found a 25% rate of CTX-M type genes, this rate rose to 69% in 2004 and the most common one was CTX-M-15 followed by CTX-M-16, -8, and -14 [26] . A study in Thailand identified the gene prevalence for CTX-M as 99.3%, TEM as 77%, SHV as 3.8%, VEB-1 as 8.5%, and OXA-10 as 8.1% with PER and GES genes not identified in any isolate [27] . Other studies in the world showed the prevalences of bla TEM and bla SHV genes in E. coli were 46.4% and 11.2%, respectively [28] , and CTX-M types have been reported as the most frequent ESBLs (65%) among Enterobacteriaceae isolates [29] .The prevalences of bla TEM and bla SHV were 65.5% and 15%, respectively. In a study of patients with ESBLproducing E. coli, 85.4% of isolates contained a CTX-M ESBL gene [25] . Another β-LACTAMASE GENES IN ESBL-POSITIVE E. COLIstudy demonstrated that CTX-M-14 was the most common ESBL among E. coli isolates, while SHV was the predominant among K. pneumoniae isolates. It also showed the co-existence of two or more kinds of ESBL in a single isolate frequently [30] .
In Turkey, β-lactamase coding gene rates for bla CTX-M , bla TEM , bla OXA-2 , bla PER , bla SHV , and bla OXA-10 groups were found in E. coli isolates as 89.5%, 59.2%, 15.8%, 14.5%, 11.8%, and 3.9%, respectively. No bla GES and bla VEB β-lactamase genes were encountered in any isolate and 1.3% of the investigated genes were identified in all the isolates. While bla TEM and bla CTX-M genes were detected together in 25 isolates, bla CTX-M and bla TEM genes were detected alone in 20 and 2 isolates. bla SHV genes were not identified alone in any isolate [22] . In a different study from 10 hospitals, bla CTX-M1 was the most prevalent β-lactamase (83.18%), followed by bla TEM (44.09%), bla CTX-M2 (31.81%), and bla SHV (1.81%) [13] . In this study, none of the isolates were found to have bla VEB , bla GES , bla PER , bla KPC , bla VIM , and bla IMP positivity. According to the PCR result, bla CTX-M1 was the most prevalent β-lactamase (77.8%), followed by bla TEM (48.6%), bla CTX-M2 (15.7%), and bla SHV (1.42%). According to these results, more specifically bla NDM-1 type MBL coding gene was determined in 31 isolates (22.1%). To the best of our knowledge, this is the first record showing the highest prevalence of bla NDM-1 in ESBL-producing E. coli from Turkey. NDM-type enzymes are carbapenemases and they hydrolyze carbapenems such as IPM, meropenem, ETP, and doripenem. According to the high prevalence of bla NDM-1 variants in isolates, high rate of sensitivity to IPM and ETP for isolates was determined. According to CLSI, Minimal _ Inhibitory Concentration (MIC) values ≤1 and 0.5 μg/mL are accepted as sensitive for IPM and ETP, respectively and Nordmann reported that isolates from Enterobacteriaceae carrying bla NDM-1 have MIC values 0.5→32 for IPM and 0.38→32 for ETP. This means that there are some other factors affecting the resistance against antimicrobials besides carbapenemases [31] . The use of some kind of antibiotics such as fluoroquinolones might facilitate the widespread dissemination of ESBL-producing bacteria in the healthcare setting [32] .
The important dissemination of ESBL and carbapenemases-producing E. coli has lead to a decrease in therapeutic options. The findings indicate that CTX-M1 type β-lactamases are the most frequent among ESBL-producing E. coli isolates in our hospital. Although TEM rapidly grow in Turkey, CTX-M1 is still the most frequent CTX-M type β-lactamases. Updates of trends for regional epidemiological data on the prevalence of the β-lactamase genes and antimicrobial resistance are crucial in order to promote appropriate antimicrobial therapy as well as an effective infection control and clinical care management.
